Merck Reports Q3 2026 Sales and Raises Outlook
Merck & Co. (NYSE: MRK), known as MSD outside the United States and Canada, reported third-quarter 2026 worldwide sales of $18.1 billion, representing a 5% increase year-over-year, or 4% excluding ... Read More